From Missouri City, Texas, USA:
My 13 old daughter, who has had diabetes since age four, developed juvenile rheumatoid arthritis (JRA) at age nine, and we have had problems coordinating the effects of one disease with the other, particularly medication for JRA. Is there a specialty that could handle both diseases?
Typeá1A (autoimmune) diabetes is quite often associated with other autoimmune disorders in the Autoimmune Polyglandular Syndrome, but although JRA is also a disorder of the immune system the two are found together rather uncommonly. Probably for this reason there is no recognised sub-discipline for their care.
In your daughter's case, I think that the first step might be to assess how much the stress of having two chronic conditions is affecting blood glucose control. The Medical Social Worker on her diabetes team would be a good person to ask for help. Aside from that, it is essential that the respective doctors for the diabetes and the JRA communicate with each other if only to ensure that there is minimal use of drugs like methylpredisone for the arthritis.
In the end, it will be the diabetes care that has to be and can be the most flexible component. It might be a good idea for example to consider an insulin pump with its many possibilities for adapting insulin administration, and with it one of the essentially painless blood glucose devices like the FreeStyle or One Touch® Ultra.
Original posting 24 May 2001
Posted to Other Illnesses
Last Updated: Tuesday April 06, 2010 15:09:22
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
© Children with Diabetes, Inc. 1995-2017. Comments and Feedback.